AMGN R&D to Revenue

Amgen · R&D to Revenue

AMGN logo

AMGN R&D to Revenue

Latest reported18.98%
AMGN FY R&D/Revenue (0.00% → 18.98%)
High-resolution chart · PNG

AMGN r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
18.9815%
17.8435%
16.9706%
16.8446%
24.3427%
16.5474%
17.6184%
15.7367%
15.5893%
16.7022%
18.7887%
21.4175%
21.8623%
19.5772%
20.3247%
19.2254%
19.5602%
20.196%
22.1109%
23.5913%
18.6163%
19.2227%
19.8061%
20.2245%
21.5405%
24.5041%
25.6788%
25.1031%
26.8918%
24.0344%
23.7262%
19.9753%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.